We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




GE and CADx Sign Distribution Agreement

By HospiMedica staff writers
Posted on 27 Aug 2003
Print article
An agreement to distribute two new computer-aided detection (CAD) technologies has been announced by GE Medical Systems (Waukesha, WI, USA) and CADx Systems, Inc. (Beavercreek, OH, USA).

The technologies, developed by CADx, are Second Look Digital and Second Look AD. Designed to help doctors detect breast cancer, both products are to be integrated with the Senographe 2000D full-field mammography system of GE, to be marketed by both GE and CADx. The Second Look products utilize software technology to highlight potential areas of concern, calling attention to subtle changes in tissue that may indicate the presence of cancer in the breast. After viewing a patient's mammogram, radiologists refer to the CAD results to assist their decision regarding the most appropriate course of treatment. The Second Look AD system has both analog and digital capabilities to provide greater flexibility for doctors and to provide smooth transition from film-based systems to full-field digital systems.

"We are excited to be taking another step toward providing healthcare professionals and patients with the most advanced technology available in breast imaging,” said Michelle Heying, general manager of mammography, GE Medical Systems.




Related Links:
GE Medical Systems
CADx Systems
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Facet Fixation System
ZYFUSE
New
Wound Care Cart
UMGKA-3669-LTG

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.